Pfizer breaks away from pack in pharma league table

Related tags Cent Pharmaceutical industry Ims health Pfizer

US pharmaceutical major Pfizer reinforced its position as the
world's largest drug company in 2002 after putting in sales of
$29.45 billion (€25.12 bn) in 2002, a hike of 11 per cent over the
prior year, according to a new analysis by IMS Health. And the firm
will likely extend its lead in 2003, now that it has completed its
$60-billion acquisition of Pharmacia, in tenth place in the
rankings with sales of $12.26 billion (+8 per cent).

US pharmaceutical major Pfizer reinforced its position as the world's largest drug company in 2002 after putting in sales of $29.45 billion (€25.12 bn) in 2002, a hike of 11 per cent over the prior year, according to a new analysis by IMS Health. And the firm will likely extend its lead in 2003, now that it has completed its $60-billion acquisition of Pharmacia, in tenth place in the rankings with sales of $12.26 billion (+8 per cent).

Europe's largest drugmaker, GlaxoSmithKline, came second in the league table with sales of $27.88 billion, but lagged in terms of growth with a 7 per cent hike over 2001. Merck & Co, for many years the number one company but which has slipped down the rankings after eschewing the merger-mania of the 1990s, came in third with sales of $19.97 billion, up 6 per cent.

In terms of revenue growth, fourth-placed Johnson & Johnson led the group, with sales up 15 per cent to $18.55 billion. AstraZeneca's $18.12 billion turnover (+9 per cent) gave it the fifth spot, followed by Novartis ($16.6 billion; +13 per cent) and Aventis ($14.30 billion; +11 per cent).

Related news

Related products

show more

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

Indena | 25-Oct-2022 | Technical / White Paper

Indena is well known in the space of naturally derived molecules, with a know-how developed over its one hundred year history. At the same time, the company...

Related suppliers

Follow us

Products

View more

Webinars